Expression of new antigens on tumor cells by inhibiting nonsense-mediated mRNA decay

Human cancer regression antigens

(2013) Pia Kvistborg et al.   CURRENT OPINION IN IMMUNOLOGY

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials

(2013) Sebastian P Haen et al.   CURRENT OPINION IN IMMUNOLOGY

From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer

(2013) Helen Angell et al.   CURRENT OPINION IN IMMUNOLOGY

Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers

(2011) Fernando Pastor et al.   MOLECULAR THERAPY

Natural immunity to cancer in humans

(2010) Gabriela Bindea et al.   CURRENT OPINION IN IMMUNOLOGY

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

(2010) Fernando Pastor et al.   NATURE

Aptamers as therapeutics

(2010) Anthony D. Keefe et al.   NATURE REVIEWS DRUG DISCOVERY

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

(2009) Justin P Dassie et al.   NATURE BIOTECHNOLOGY

Recognition and elimination of nonsense mRNA

(2008) O MUHLEMANN et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

(2008) T. Schulze et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Development of targeted oncolytic virotherapeutics through translational research

(2008) Ta-Chiang Liu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Specificity in cancer immunotherapy

(2008) Andrea Schietinger et al.   SEMINARS IN IMMUNOLOGY